Viemed Healthcare, INC 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
NASDAQ
Viemed Healthcare reported 20.5% revenue growth and a 34.8% rise in net income for 2025, expanded via acquisitions, resupply programs, and home respiratory care, while authorizing a new 2026 share buyback.
NASDAQ
Viemed Healthcare's 2024 annual report reveals revenue growth and strategic advancements in home medical equipment and respiratory care services.
NASDAQ
Viemed Healthcare, Inc.'s 10-K filing outlines the company's share structure, regulatory compliance, and financial performance for the year ended December 31, 2023.